Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease.

Espen Ø BjørnestadIndu DharGard F T SvingenEva R PedersenStein ØrnMads M SvenningssonGrethe S TellPer M UelandGerhard SuloReijo LaaksonenOttar Nygård

Published in: Journal of internal medicine (2022)

Circulating TMAO did not predict long-term all-cause, CV, or non-CV mortality in patients with coronary heart disease or in community-based adults. This large study does not support a role of TMAO for patient risk stratification in primary or secondary prevention.

Keyphrases

cardiovascular events
case report
risk factors
type diabetes
cardiovascular disease
free survival